Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis

• MENTER A

収録刊行物

• Arch Dermatol

  Arch Dermatol 141 31-38, 2005

詳細情報

• CRID: 1572261551076532864
• NII論文ID: 30005398515
• DOI: 10.1001/archderm.141.1.31
• データソース種別:
  • CiNii Articles